Nucleic Acid Nanorobotics (NANs): A Novel Platform for Oligonucleotide Therapeutics Bioanalysis
- Introducing NAN technology and its application for siRNA and ASO quantification
- Highlighting core platform capabilities, including sensitivity and robustness across complex biological matrices
- Exhibiting published evidence demonstrating accuracy, precision, and applicability to live-sample pharmacokinetic bioanalysis